MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

iPLA2β controls ER-mitochondria tethering and Ca2+ transfer in Parkinson’s disease

ZH. Lin, Y. Liu, NJ. Xue, BR. Zhang, JL. Pu (Hangzhou, China)

Meeting: 2024 International Congress

Abstract Number: 908

Keywords: Mitochondrial dysfunction, Parkinson’s

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: In this study, we aimed to investigate whether Parkinson’s disease (PD) associated calcium-independent phospholipase A2β (iPLA2β) regulates the integrity and functions of endoplasmic reticulum (ER)-mitochondria contacts

Background: Phospholipase A2 group VI (PLA2G6) is an autosomal recessive pathogenic gene of PD, which encodes the iPLA2β protein. The iPLA2β is widely distributed within cells, including the ER and mitochondria, and is able to regulate the functions of both organelles. However, whether the iPLA2β protein is involved in the regulation of ER-mitochondria contacts, also known as mitochondria-associated ER membrane (MAM), remains unknown.

Method: The effects of PLA2G6 mutation or deletion on the interaction between ER and mitochondria were detected using skin fibroblasts derived from patients with PD harboring PLA2G6 mutations, N2a Pla2g6 KO cells, and the Pla2g6 KO mice model. The Ca2+ transport from ER to mitochondria and mitochondrial ATP production were examined using real-time organelle Ca2+ fluorescence monitoring and oxygen consumption rate (OCR) assay. The MAM structure was isolated and purified from N2a cells, mice and human brains by differential centrifugation, and western blot (WB) was used to determine whether iPLA2β proteins were present in the MAM. The iPLA2β protein interactome in the MAM was searched and identified by mass spectrometry (MS), co-immunoprecipitation (co-IP), proximity ligation assay (PLA), blue native-polyacrylamide gel electrophoresis (BN-PAGE) experiments.

Results: We found that iPLA2β functions in controlling the ER-mitochondria contacts and Ca2+ transfer both in vitro and in vivo. Furthermore, the iPLA2β protein was found to be enriched in the MAM to physically interact with the inositol 1,4,5-trisphosphate receptor 1 (IP3R1)/glucose-regulated protein 75 (GRP75)/voltage-dependent anion channel 1 (VDAC1) complex and protect the integrity of this complex.

Conclusion: The iPLA2β protein was localized in the MAM to maintain the integrity and functions of MAM.

To cite this abstract in AMA style:

ZH. Lin, Y. Liu, NJ. Xue, BR. Zhang, JL. Pu. iPLA2β controls ER-mitochondria tethering and Ca2+ transfer in Parkinson’s disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/ipla2%ce%b2-controls-er-mitochondria-tethering-and-ca2-transfer-in-parkinsons-disease/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/ipla2%ce%b2-controls-er-mitochondria-tethering-and-ca2-transfer-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley